[Acute hemolytic anemia consequent to administration of nitrofuran and novalgine, in 2 patients with erythrocytic glucose-6-phosphate dehydrogenase].
D000208:Acute Disease; D000743:Anemia, Hemolytic / Q000139:chemically induced*; D004912:Erythrocytes / Q000201:enzymology; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000150:complications*; D006801:Humans; D007565:Jaundice / Q000139:chemically induced; D008297:Male; D008744:Methylamines / Q000627:therapeutic use; D008875:Middle Aged; D009581:Nitrofurans / Q000009:adverse effects* / Q000627:therapeutic use; D011720:Pyrazoles / Q000009:adverse effects* / Q000627:therapeutic use; D013451:Sulfonic Acids / Q000009:adverse effects* / Q000627:therapeutic use; D014514:Ureteral Calculi / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy
D008744:Methylamines; D009581:Nitrofurans; D011720:Pyrazoles; D013451:Sulfonic Acids
Anémie hémolytique aiguë consécutive à l'administration de nitrofurane et de novalgine chez deux malades présentant un déficit en glucose-6-phosphate-dehydrogenase érythrocytaire